Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
about
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential.Breast Cancer Immunotherapy: Facts and Hopes.Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment.Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
P2860
Q37015722-22CB19DA-ACD0-425B-AD1B-97F4E22BA6D6Q37225613-CAD362AB-B9B3-4AB1-8DEC-F1AA80F45788Q38628198-ECAFBBDB-3062-465B-BCAE-57F535EAB5FAQ39110347-3C216B41-7A57-4090-86E9-FC32628961A4Q47115510-2072094E-873A-490C-A0C6-8E6A97974914Q47156322-57317E06-BC82-4C24-A5D5-A358CF87CAEFQ52718405-E82037C7-99A2-41A6-A20F-01367DEDA66CQ53721205-86CE0285-D6F8-4424-8658-A612C448778C
P2860
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@ast
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@en
type
label
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@ast
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@en
prefLabel
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@ast
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@en
P2093
P2860
P50
P1476
Improved Natural Killer cell a ...... oing neoadjuvant chemotherapy.
@en
P2093
D Crivellari
D Lombardi
D Martorelli
R Talamini
S Spazzapan
P2860
P2888
P356
10.1186/S12967-015-0567-0
P50
P577
2015-06-27T00:00:00Z
P5875
P6179
1025710529